Tumor-derived Variants of Epstein-Barr Virus Latent Membrane Protein 1 Induce Sustained Erk Activation and c-Fos
Open Access
- 1 December 2008
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 283 (52), 36573-36585
- https://doi.org/10.1074/jbc.m802968200
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Epstein-Barr Virus-Encoded LMP1 Regulates Epithelial Cell Motility and Invasion via the ERK-MAPK PathwayJournal of Virology, 2008
- Structural variability of the carboxy‐terminus of Epstein–Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomasJournal of Medical Virology, 2007
- LMP1 Strain Variants: Biological and Molecular PropertiesJournal of Virology, 2006
- Molecular interpretation of ERK signal duration by immediate early gene productsNature, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Epstein–Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFκB pathwayGenes & Immunity, 2001
- Epstein-Barr Virus LMP-1 Natural Sequence Variants Differ in Their Potential To Activate Cellular Signaling PathwaysJournal of Virology, 2001
- Characterization of Intercellular Adhesion Molecule-1 Regulation by Epstein-Barr Virus-encoded Latent Membrane Protein-1 Identifies Pathways That Cooperate with Nuclear Factor κB to Activate TranscriptionJournal of Biological Chemistry, 2001
- Localization of the Major NF-κB-activating Site and the Sole TRAF3 Binding Site of LMP-1 Defines Two Distinct Signaling MotifsJournal of Biological Chemistry, 1997
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cellsCell, 1985